Arun Singh

6PUBLICATIONS
9CO-AUTHORS
PharmacogenomicsBehavioural epidemiologyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 20, 2023
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study.

Cesar Giron-Hernandez, Joong Hee Han, Roberta Alberio

|Jul 09, 2022
Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study.

Erica A Voss, Saberi Rana Ali, Arun Singh

|Oct 11, 2021
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.

Gang Li, Alexander Keenan, Mehmet Daskiran

|Aug 06, 2020
Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire.

Clifton Blackwood, Panna Sanga, Isaac Nuamah

|Jul 02, 2020
Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies.

Maju Mathews, Srihari Gopal, Arun Singh

|Mar 19, 2020
Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study.

Srihari Gopal, Jagadish Gogate, Katalin Pungor

Pageof 1

Frequent Collaborators

5 joint publications

Srihari Gopal

3 joint publications

Katalin Pungor

2 joint publications

Edward Kim

1 joint publications

Wilson Tan